Skip to main content

Table 1 Demographic and headache characteristics of participants

From: Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders

 

TPM + NTP N = 44

TPM + Placebo N = 17

NTP + Placebo N = 19

Demographics

36 women (81.8%) Ages 36 ± 9.55

15 women (88.2%) Ages 35.7 ± 8.2

16 women (84.2%) Ages 41.5 ± 6.72

8 men (18.2%) Ages 36.6 ± 9.47

2 men (11.8%) Ages 36–38

3 men (15.8%) Ages 39.6 ± 6.77

Baseline headache days/month

8.1

8

8

  1. * Age presented as mean ± standard deviation